A collaborative effort between investigators at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) and Massachusetts General Hospital (MGH), a founding ...
Carmeliet, P. et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Med. 5 , 495–502 (1999).
SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread ...
These efforts include using an adeno-associated virus carrying a gene encoding a fragment of an anti-VEGF antibody, gene silencing, and gene editing using the CRISPR system. Since treatments already ...
In March 2023, the Organising Committee of the Third International Summit on Human Genome Editing published a statement ...
News Medical on MSN1d
Gene editing restores treatment sensitivity in melanomaIn a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...
CRISPR-Cas has transformed our ability to edit DNA sequences, with broad spectrum applications in agriculture, health, and ...
The global gene editing tool market is expected to surge at a compound annual growth rate (CAGR) of 18.4% from 2024 to 2034, exceeding the previous growth rate of 17.4% (2019-2023). The market value ...
In a potential advance for melanoma patients, researchers at ChristianaCare’s Gene Editing Institute have used CRISPR gene editing tools to disable a gene mutation often seen in aggressive forms of ...
News Medical on MSN6d
Grant supports gene-editing research for rare metabolic diseasesA $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at ...
News Medical on MSN11h
Gene editing approach helps launch first-in-human clinical trial for rare genetic diseaseA collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...
Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback